Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(0.0%)
USD 46.75
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.06 Billion EUR | -5.71% |
| 2022 | 1.12 Billion USD | -0.7% |
| 2021 | 1.13 Billion USD | -3.22% |
| 2020 | 1.17 Billion USD | 38.85% |
| 2019 | 842.86 Million USD | 257.79% |
| 2018 | 235.57 Million EUR | 2.13% |
| 2017 | 230.67 Million EUR | 1.5% |
| 2016 | 227.26 Million EUR | 1.77% |
| 2015 | 223.31 Million EUR | 7.51% |
| 2014 | 207.71 Million EUR | 1.35% |
| 2013 | 204.94 Million EUR | 12.56% |
| 2012 | 182.07 Million EUR | 3.42% |
| 2011 | 176.05 Million EUR | 7.94% |
| 2010 | 163.1 Million EUR | 3.69% |
| 2009 | 157.3 Million EUR | -15.63% |
| 2008 | 186.44 Million EUR | 10.12% |
| 2007 | 169.31 Million EUR | 13.41% |
| 2006 | 149.29 Million EUR | 2.91% |
| 2005 | 145.07 Million EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 1.23 Billion EUR | 0.0% |
| 2023 Q4 | 1.06 Billion EUR | 0.0% |
| 2023 FY | 1.06 Billion EUR | -5.71% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | 1.01 Billion USD | -10.16% |
| 2023 Q2 | 985.95 Million USD | -2.41% |
| 2022 Q3 | 846.67 Million USD | -0.64% |
| 2022 Q1 | 880.22 Million EUR | 1.99% |
| 2022 Q2 | 852.1 Million EUR | -3.19% |
| 2022 Q4 | 1.12 Billion USD | 32.83% |
| 2022 FY | 1.12 Billion USD | -0.7% |
| 2021 Q1 | 838.98 Million EUR | 0.74% |
| 2021 FY | 1.13 Billion USD | -3.22% |
| 2021 Q4 | 863.08 Million EUR | -0.79% |
| 2021 Q2 | 820.01 Million EUR | -2.26% |
| 2021 Q3 | 869.98 Million EUR | 6.09% |
| 2020 Q1 | 662.44 Million EUR | 3.52% |
| 2020 Q2 | 623.26 Million EUR | -5.91% |
| 2020 Q3 | 635.76 Million EUR | 2.01% |
| 2020 Q4 | 832.85 Million EUR | 31.0% |
| 2020 FY | 1.17 Billion USD | 38.85% |
| 2019 FY | 842.86 Million USD | 257.79% |
| 2019 Q2 | 641.83 Million EUR | -0.89% |
| 2019 Q3 | 669.24 Million EUR | 4.27% |
| 2019 Q1 | 647.61 Million EUR | 174.9% |
| 2019 Q4 | 639.93 Million EUR | -4.38% |
| 2018 Q3 | 264.85 Million EUR | 14.76% |
| 2018 Q4 | 235.57 Million EUR | -11.05% |
| 2018 FY | 235.57 Million EUR | 2.13% |
| 2018 Q1 | 246.7 Million EUR | 6.95% |
| 2018 Q2 | 230.78 Million EUR | -6.46% |
| 2017 Q1 | 262.57 Million EUR | 15.54% |
| 2017 Q4 | 230.67 Million EUR | -5.23% |
| 2017 Q3 | 243.4 Million EUR | 3.08% |
| 2017 FY | 230.67 Million EUR | 1.5% |
| 2017 Q2 | 236.13 Million EUR | -10.07% |
| 2016 Q2 | 230.3 Million EUR | -0.15% |
| 2016 FY | 227.26 Million EUR | 1.77% |
| 2016 Q3 | 240.03 Million EUR | 4.23% |
| 2016 Q4 | 227.26 Million EUR | -5.32% |
| 2016 Q1 | 230.66 Million EUR | 3.29% |
| 2015 FY | 223.31 Million EUR | 7.51% |
| 2015 Q2 | 223.34 Million EUR | -5.65% |
| 2015 Q3 | 236.21 Million EUR | 5.76% |
| 2015 Q4 | 223.31 Million EUR | -5.46% |
| 2015 Q1 | 236.7 Million EUR | 13.96% |
| 2014 Q1 | 242.63 Million EUR | 18.39% |
| 2014 FY | 207.71 Million EUR | 1.35% |
| 2014 Q3 | 236.71 Million EUR | 3.61% |
| 2014 Q2 | 228.45 Million EUR | -5.84% |
| 2014 Q4 | 207.71 Million EUR | -12.25% |
| 2013 Q1 | 205.17 Million EUR | 12.69% |
| 2013 FY | 204.94 Million EUR | 12.56% |
| 2013 Q3 | 215.47 Million EUR | 5.91% |
| 2013 Q2 | 203.44 Million EUR | -0.85% |
| 2013 Q4 | 204.94 Million EUR | -4.89% |
| 2012 FY | 182.07 Million EUR | 3.42% |
| 2012 Q3 | 193.7 Million EUR | -0.62% |
| 2012 Q4 | 182.07 Million EUR | -6.0% |
| 2012 Q2 | 194.91 Million EUR | -4.4% |
| 2012 Q1 | 203.88 Million EUR | 15.81% |
| 2011 Q3 | 194.51 Million EUR | 7.94% |
| 2011 Q4 | 176.05 Million EUR | -9.49% |
| 2011 FY | 176.05 Million EUR | 7.94% |
| 2011 Q1 | 191.33 Million EUR | 17.31% |
| 2011 Q2 | 180.2 Million EUR | -5.82% |
| 2010 Q2 | 188.36 Million EUR | 0.56% |
| 2010 Q4 | 163.1 Million EUR | -13.9% |
| 2010 Q1 | 187.3 Million EUR | 19.07% |
| 2010 Q3 | 189.42 Million EUR | 0.57% |
| 2010 FY | 163.1 Million EUR | 3.69% |
| 2009 FY | 157.3 Million EUR | -15.63% |
| 2009 Q4 | 157.3 Million EUR | 0.0% |
| 2008 FY | 186.44 Million EUR | 10.12% |
| 2007 FY | 169.31 Million EUR | 13.41% |
| 2006 FY | 149.29 Million EUR | 2.91% |
| 2005 FY | 145.07 Million EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -45025.676% |
| Ansell Limited | 1.32 Billion USD | 20.266% |
| Ansell Limited | 1.33 Billion USD | 20.416% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -739.324% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -112327.32% |
| Psykey, Inc. | 2.47 Million USD | -42760.746% |
| ConvaTec Group Plc | 2.01 Billion USD | 47.458% |
| ConvaTec Group Plc | 2.02 Billion USD | 47.532% |
| Encision Inc. | 1.98 Million USD | -53347.586% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -34775.525% |
| Innovative MedTech Inc. | 6.13 Million USD | -17184.599% |
| LifePoint, Inc. | 2.45 Million USD | -43107.416% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -10315.313% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -31087.735% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -34777.314% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -136489.384% |
| SmileDirectClub, Inc. | 982.26 Million USD | -7.953% |
| Sector 10, Inc. | 9.84 Million USD | -10670.309% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 21.784% |
| SheerVision, Inc. | 1.43 Million USD | -73979.976% |
| United Health Products, Inc. | 1.99 Million USD | -52949.149% |
| Vasamed, Inc. | 1 Million USD | -105379.26% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -27802.723% |
| Yubo International Biotech Limited | 2.91 Million USD | -36290.208% |